BioCatalystWatch
CORTWorkspace / CORT / OverviewCompany library
CORCEPT THERAPEUTICS INC logo

CORCEPT THERAPEUTICS INC

CORCEPT THERAPEUTICS INC (CORT)

Website

Price
Market cap
Next catalystDec 17, 2026Relacorilant — Cushing's syndrome · Regulatory decisionCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Dazucorilant

GR

PreINDP1P2FilingApproved
Upcoming / outlook

Miricorilant

GR

PreINDP1P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Dazucorilant

GR

PreINDP1P2FilingApproved
Upcoming / outlook

Other pipelines

Partner / License out

Approved / commercial

Relacorilant (Lifyorli)

GR

PreINDP1P2P3FilingApproved
Upcoming / outlook

History / paused

Miricorilant

GR

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CORT PR & News

PR & News

CORT SEC archive